Floatz logo

Therapeutic Asset Ratings

9,928 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Bet Bromodomain Inhibitor Zen-3694
Colorectal Cancer
National Cancer Institute (NCI)P1CC (43)
bg-68501
Hormone Receptor-Positive Breast Cancer
BeiGeneP1CC (43)
Bgb-21447
Hormone Receptor-Positive Breast Cancer
BeOne MedicinesP1CC (43)
Bgb-21447
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
BeOne MedicinesP1CC (43)
Bgb-21447
B-Cell Chronic Lymphocytic Leukemia
BeOne MedicinesP1CC (43)
Bgb-21447
Follicular Lymphoma
BeOne MedicinesP1CC (43)
Bgb-21447
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
BeOne MedicinesP1CC (43)
Bgb-21447
Marginal Zone Lymphoma
BeOne MedicinesP1CC (43)
Bgb-21447
Non-Hodgkin Lymphoma
BeOne MedicinesP1CC (43)
Bgb-21447
Richter Transformation
BeOne MedicinesP1CC (43)
Bgb-53038
Esophageal Adenocarcinoma
BeOne MedicinesP1CC (43)
Bgb-53038
Gastric Cancer
BeOne MedicinesP1CC (43)
Bgb-53038
Gastroesophageal Junction Adenocarcinoma
BeOne MedicinesP1CC (43)
Bgb-53038
Non-Small Cell Lung Carcinoma
BeOne MedicinesP1CC (43)
Bgb-B2033
Yolk Sac Tumor
BeOne MedicinesP1CC (43)
Bgb-B2033
Non-Small Cell Squamous Lung Carcinoma
BeOne MedicinesP1CC (43)
Bgb-B2033
Hepatocellular Carcinoma
BeOne MedicinesP1CC (43)
bi 3819026
Metastatic Malignant Neoplasm
Boehringer IngelheimP1CC (43)
bi 765049
Gastric Carcinoma
Boehringer IngelheimP1CC (43)
bi 770371
Head And Neck Squamous Cell Carcinoma
Boehringer IngelheimP1CC (43)
BICALUTAMIDE
Metabolic Dysfunction-Associated Steatotic Liver Disease
University of California, San FranciscoP1CC (43)
BICALUTAMIDE
Polycystic Ovary Syndrome
University of California, San FranciscoP1CC (43)
BICALUTAMIDE
Malignant Glioma
University of NebraskaP1CC (43)
Biib115
Spinal Muscular Atrophy
BiogenP1CC (43)
Biological Ni-1801
Ovarian Endometrioid Adenocarcinoma
Light Chain Bioscience - Novimmune SAP1CC (43)
Showing 1301 to 1325 of 9,928 assets
PreviousPage 53 of 398Next